4//SEC Filing
PANDIT VIKRAM S 4
Accession 0000950103-25-016153
CIK 0001297989other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:54 PM ET
Size
20.3 KB
Accession
0000950103-25-016153
Insider Transaction Report
Form 4
Orogen Echo LLC
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
PANDIT VIKRAM S
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Orogen Group LLC
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Orogen Holdings LLC
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Atairos-Orogen Holdings, LLC
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Atairos Group, Inc.
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Atairos Partners, L.P.
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Atairos Partners GP, Inc.
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Angelakis Michael J
Director
Transactions
- Disposition to Issuer
Common Stock
2025-12-15$40.83/sh−1,551,970$63,373,143→ 0 total(indirect: See Footnotes)
Footnotes (4)
- [F1]On December 15, 2025, Issuer repurchased 1,551,970 shares of the Company's common stock from Orogen Echo LLC ("OE") pursuant to the terms of the Stock Purchase Agreement by and between the Issuer and OE, dated December 15, 2025.
- [F2]The reported number of securities has been adjusted to reflect the impact of the 5-for-1 forward stock split effective August 1, 2023.
- [F3]Vikram Pandit serves on the Board and is the Chairman and Chief Executive Officer of OE. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.
- [F4]Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
Documents
Issuer
ExlService Holdings, Inc.
CIK 0001297989
Entity typeother
Related Parties
1- filerCIK 0001183417
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 6:54 PM ET
- Size
- 20.3 KB